These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11571237)

  • 1. Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.
    Kass DA; Shapiro EP; Kawaguchi M; Capriotti AR; Scuteri A; deGroof RC; Lakatta EG
    Circulation; 2001 Sep; 104(13):1464-70. PubMed ID: 11571237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension.
    Zieman SJ; Melenovsky V; Clattenburg L; Corretti MC; Capriotti A; Gerstenblith G; Kass DA
    J Hypertens; 2007 Mar; 25(3):577-83. PubMed ID: 17278974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys.
    Vaitkevicius PV; Lane M; Spurgeon H; Ingram DK; Roth GS; Egan JJ; Vasan S; Wagle DR; Ulrich P; Brines M; Wuerth JP; Cerami A; Lakatta EG
    Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1171-5. PubMed ID: 11158613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines.
    Shapiro BP; Owan TE; Mohammed SF; Meyer DM; Mills LD; Schalkwijk CG; Redfield MM
    Circulation; 2008 Sep; 118(10):1002-10. PubMed ID: 18711013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosslink breakers: a new approach to cardiovascular therapy.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Curr Opin Cardiol; 2004 Jul; 19(4):336-40. PubMed ID: 15218393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakers of advanced glycation end products restore large artery properties in experimental diabetes.
    Wolffenbuttel BH; Boulanger CM; Crijns FR; Huijberts MS; Poitevin P; Swennen GN; Vasan S; Egan JJ; Ulrich P; Cerami A; Lévy BI
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4630-4. PubMed ID: 9539789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial.
    Oudegeest-Sander MH; Olde Rikkert MG; Smits P; Thijssen DH; van Dijk AP; Levine BD; Hopman MT
    Exp Gerontol; 2013 Dec; 48(12):1509-17. PubMed ID: 24400341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of C36, a novel breaker of advanced glycation endproducts cross-links, on the cardiovascular system of diabetic rats.
    Cheng G; Wang LL; Long L; Liu HY; Cui H; Qu WS; Li S
    Br J Pharmacol; 2007 Dec; 152(8):1196-206. PubMed ID: 17965740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture.
    Ahimastos AA; Natoli AK; Lawler A; Blombery PA; Kingwell BA
    Hypertension; 2005 Jun; 45(6):1194-9. PubMed ID: 15897362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.
    Bakris GL; Bank AJ; Kass DA; Neutel JM; Preston RA; Oparil S
    Am J Hypertens; 2004 Dec; 17(12 Pt 2):23S-30S. PubMed ID: 15607432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of arterial stiffness should discriminate between systolic and diastolic pressure ranges.
    Hermeling E; Hoeks AP; Winkens MH; Waltenberger JL; Reneman RS; Kroon AA; Reesink KD
    Hypertension; 2010 Jan; 55(1):124-30. PubMed ID: 19933922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats.
    Susic D; Varagic J; Ahn J; Frohlich ED
    Am J Hypertens; 2004 Apr; 17(4):328-33. PubMed ID: 15062886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial wave reflection during antihypertensive therapy with barnidipine: a 6-month, open-label study using an integrated cardiovascular ultrasound approach in patients with newly diagnosed hypertension.
    Palombo C; Malshi E; Morizzo C; Rakebrandt F; Corretti V; Santini F; Fraser AG; Kozakova M
    Clin Ther; 2009 Dec; 31(12):2873-85. PubMed ID: 20110026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic Influences of Bisoprolol in Hypertensive Middle-Aged Men: A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study.
    Suojanen L; Haring A; Tikkakoski A; Koskela JK; Tahvanainen AM; Huhtala H; Kähönen M; Sipilä K; Eräranta A; Mustonen JT; Kivistö K; Pörsti IH
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):130-137. PubMed ID: 28256104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats.
    Xu Q; Chakravorty A; Bathgate RA; Dart AM; Du XJ
    Hypertension; 2010 May; 55(5):1260-6. PubMed ID: 20351343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potassium magnesium supplementation for four weeks improves small distal artery compliance and reduces blood pressure in patients with essential hypertension.
    Wu G; Tian H; Han K; Xi Y; Yao Y; Ma A
    Clin Exp Hypertens; 2006 Jul; 28(5):489-97. PubMed ID: 16820345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes.
    Aronson D
    J Hypertens; 2003 Jan; 21(1):3-12. PubMed ID: 12544424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive method for determination of arterial compliance using Doppler echocardiography and subclavian pulse tracings. Validation and clinical application of a physiological model of the circulation.
    Marcus RH; Korcarz C; McCray G; Neumann A; Murphy M; Borow K; Weinert L; Bednarz J; Gretler DD; Spencer KT
    Circulation; 1994 Jun; 89(6):2688-99. PubMed ID: 8205683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose treatment with angiotensin II receptor blocker in patients with hypertension: differential effect of tissue protection versus blood pressure lowering.
    Shargorodsky M; Hass E; Boaz M; Gavish D; Zimlichman R
    Atherosclerosis; 2008 Mar; 197(1):303-10. PubMed ID: 17588581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.